TGAM
ABBV icon

TBH Global Asset Management’s AbbVie ABBV Stock Holding History

TBH Global Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
8,024
+46
+0.6% +$9.9K 0.37% 67
2026
Q1 		$1.74M Sell
7,978
-372
-4% -$82.5K 0.35% 70
2025
Q4 		$1.91M Buy
8,350
+493
+6% +$112K 0.32% 68
2025
Q3 		$1.82M Sell
7,857
-129
-2% -$26.3K 0.36% 72
2025
Q2 		$1.48M Buy
7,986
+220
+3% +$40.9K 0.32% 59
2025
Q1 		$1.63M Buy
7,766
+292
+4% +$56.8K 0.31% 53
2024
Q4 		$1.33M Buy
7,474
+399
+6% +$73.4K 0.31% 78
2024
Q3 		$1.4M Sell
7,075
-180
-2% -$33.6K 0.3% 79
2024
Q2 		$1.24M Sell
7,255
-391
-5% -$64.8K 0.28% 82
2024
Q1 		$1.39M Buy
7,646
+452
+6% +$77.9K 0.28% 66
2023
Q4 		$1.11M Sell
7,194
-341
-5% -$49.7K 0.23% 78
2023
Q3 		$1.12M Buy
7,535
+9
+0.1% +$1.32K 0.22% 83
2023
Q2 		$1.01M Sell
7,526
-14
-0.2% -$2.05K 0.2% 85
2023
Q1 		$1.2M Buy
7,540
+262
+4% +$40.1K 0.26% 73
2022
Q4 		$1.18M Buy
7,278
+88
+1% +$13.5K 0.29% 68
2022
Q3 		$965K Buy
7,190
+10
+0.1% +$1.44K 0.25% 68
2022
Q2 		$1.1M Buy
7,180
+172
+2% +$26.3K 0.26% 70
2022
Q1 		$1.14M Buy
7,008
+8
+0.1% +$1.16K 0.24% 75
2021
Q4 		$948K Buy
7,000
+58
+0.8% +$6.85K 0.2% 84
2021
Q3 		$749K Buy
6,942
+123
+2% +$14.1K 0.17% 93
2021
Q2 		$768K Buy
6,819
+6
+0.1% +$676 0.18% 92
2021
Q1 		$737K Buy
6,813
+141
+2% +$15.1K 0.19% 90
2020
Q4 		$715K Sell
6,672
-551
-8% -$53K 0.22% 85
2020
Q3 		$633K Buy
7,223
+905
+14% +$85.2K 0.22% 84
2020
Q2 		$620K Buy
6,318
+4
+0.1% +$352 0.25% 74
2020
Q1 		$481K Buy
6,314
+3
+0% +$256 0.2% 81
2019
Q4 		$559K Buy
+6,311
New +$524K 0.17% 88

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TBH Global Asset Management's ABBV Position: Q2 2026 in Review

TBH Global Asset Management increased its AbbVie (ABBV) stake by 0.58% in Q2 2026, buying an estimated $9.9K and bringing the position to 8,024 shares worth $2.02M. The position accounts for 0.37% of the portfolio, ranked #67.

TBH Global Asset Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TBH Global Asset Management held 8,024 shares of AbbVie worth $2.02M as of Q2 2026.
  • TBH Global Asset Management bought 46 AbbVie shares in Q2 2026, an estimated $9.9K.
  • AbbVie made up 0.37% of TBH Global Asset Management's portfolio in Q2 2026, its #67 holding.
  • TBH Global Asset Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TBH Global Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.